PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31730632-5 2019 We then derived a mathematical model that can predict the conjugation capacities of mutant UGT1A1s by using results of substrate docking in silico and results of in vitro analysis of glucuronidation of acetaminophen and 17beta-estradiol by UGT1A1s. Acetaminophen 202-215 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 91-97 31730632-5 2019 We then derived a mathematical model that can predict the conjugation capacities of mutant UGT1A1s by using results of substrate docking in silico and results of in vitro analysis of glucuronidation of acetaminophen and 17beta-estradiol by UGT1A1s. Acetaminophen 202-215 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 240-246 28932176-2 2017 The present research was aimed to study the effect of 2 important single nucleotide polymorphisms (SNPs; rs8330 and rs10929303) of UGT1A1 gene on glucuronidation status of acetaminophen in healthy volunteers (n = 109). Acetaminophen 172-185 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 131-137 28932176-4 2017 The in vivo activity of UGT1A1 was investigated by high-performance liquid chromatography-based analysis of glucuronidation status (ie, acetaminophen and acetaminophen glucuronide) in human volunteers after oral intake of a single dose (1000 mg) of acetaminophen. Acetaminophen 136-149 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 24-30 28932176-4 2017 The in vivo activity of UGT1A1 was investigated by high-performance liquid chromatography-based analysis of glucuronidation status (ie, acetaminophen and acetaminophen glucuronide) in human volunteers after oral intake of a single dose (1000 mg) of acetaminophen. Acetaminophen 154-167 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 24-30 27781231-4 2016 The control cells were treated with 10 mM acetaminophen without genistein to compare with the effects of the combination of acetaminophen and genistein on the expression of UGT1A1, 1A6 and 1A9, Nrf2 and Keap1 mRNAs, as well as the expression of Nrf2 and Keap1 proteins, which were tested by western blotting. Acetaminophen 124-137 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 173-179 23408116-7 2013 Cotransfection studies demonstrated an inhibitory effect of exon 5b containing cDNAs on acetaminophen glucuronidation by UGT1A1 and UGT1A6 cDNAs containing exon 5a. Acetaminophen 88-101 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 121-127 23279026-4 2012 It is well-known that UGT1A1, UGT1A6 and UGT1A9 enzymes glucuronidate acetaminophen. Acetaminophen 70-83 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 22-28 21235620-8 2011 Dasatinib and imatinib also inhibited UGT1A1-mediated paracetamol glucuronidation. Acetaminophen 54-65 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 38-44 15180166-2 2004 The underlying cause of GS is a polymorphism in the promotor region of the uridine diphosphate glucuronosyltransferase isoform 1A1 gene (UGT1A1*28), its encoded enzyme being responsible for the glucuronidation of bilirubin and presumably acetaminophen. Acetaminophen 238-251 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 137-143 15180166-4 2004 Patients with GS might be more susceptible to unexpected side effects while taking acetaminophen and other drugs which are substrates of UGT1A1. Acetaminophen 83-96 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 137-143 15180166-9 2004 The metabolic ratios unchanged acetaminophen/acetaminophen glucuronide in UGT1A1-wildtypes, heterozygotes and mutants showed no statistically significant differences. Acetaminophen 31-44 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 74-80 24104197-4 2014 The polymorphisms evaluated included those in genes encoding putative acetaminophen-metabolizing enzymes (UGT1A1, UGT1A6, UGT1A9, UGT2B15, SULT1A1, CYP2E1, and CYP3A5) as well as CD44 and BHMT1. Acetaminophen 70-83 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 106-112 21726413-8 2011 Glucuronidation activity towards acetaminophen of p.P364L-UGT1A1, 1A6, 1A7, 1A8, 1A9 and 1A10 was 50.3%, 46.4%, 17.2%, 44.1%, 5.0% and 42.8%, respectively, of wild-type. Acetaminophen 33-46 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 58-64 21245288-9 2011 Consistent with previous reports, APAP was glucuronidated by recombinant UGT1A1, UGT1A6, UGT1A9, and UGT2B15. Acetaminophen 34-38 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 73-79 11714888-9 2001 APAP-UGT activities correlated best with propofol-UGT (r = 0.85; UGT1A9) and bilirubin-UGT (r = 0.66; UGT1A1) activities, but poorly with UGT1A6 protein (r = 0.30). Acetaminophen 0-4 UDP glucuronosyltransferase family 1 member A1 Homo sapiens 102-108